U.S. health officials are asking for research about how hemp-derived cannabinoids and other plant-derived treatments affect chronic pain.
The review will focus on:
Submissions are due by Jan. 4.
Federal health officials solicit public for data on CBD treatments for pain
8 takeaways from FDA’s conference on CBD and gender